Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16

博士 === 中國醫藥大學 === 中國藥學暨中藥資源學系博士班 === 102 === Kalanchoe gracilis (Crassulaceae) is a traditional Chinese medicinal, a.k.a. Da-Huan-Hun, and usually used in injuries, pain, fever and inflammation in Taiwan. In 1998, enterovirus 71 (EV71) and coxsackie A16 (CVA16) outbroke with severe or even fatal cas...

Full description

Bibliographic Details
Main Authors: Ching-Ying Wang, 王靜瑩
Other Authors: Yuan-Shiun Chang
Format: Others
Language:zh-TW
Published: 2014
Online Access:http://ndltd.ncl.edu.tw/handle/5eqw58
id ndltd-TW-102CMCH5049012
record_format oai_dc
spelling ndltd-TW-102CMCH50490122019-06-27T05:13:16Z http://ndltd.ncl.edu.tw/handle/5eqw58 Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16 伽藍菜抑制腸病毒71型及克沙奇病毒A16型之活性研究 Ching-Ying Wang 王靜瑩 博士 中國醫藥大學 中國藥學暨中藥資源學系博士班 102 Kalanchoe gracilis (Crassulaceae) is a traditional Chinese medicinal, a.k.a. Da-Huan-Hun, and usually used in injuries, pain, fever and inflammation in Taiwan. In 1998, enterovirus 71 (EV71) and coxsackie A16 (CVA16) outbroke with severe or even fatal cases occurred in Taiwan, causing public health concern. EV71 and CVA16 become two major endemic agents of HFMD in children in Taiwan. There are not yet specific vaccines or antiviral drugs for treating enterovirus infection in clinic. In this study, extracts and compounds of K. gracilis leaf and stem were divided into two groups for investigating the antiviral activities against EVs. HPLC analysis indicated leaf and stem extracts exhibiting different ingredients, such as ferulic acid, quercetin and kaempferol in the leaf extract, as well as caffeic acid and eupafol in stem extracts. Plaque reduction assay indicated IC50 values of K. gracilis leaf extract were 35.88 μg/ml for EV71, and 42.91 μg/ml for CVA16, repectively. Leaf extract showed potent activity in the procedures of pre- and post-treatment for virus. Leaf extract inhibit the virus yield production to 90%. IC50 values of K. gracilis leaf extract in cell-based FRET assay were 40.82 μg/ml for EV71 and 47.84 μg/ml for CVA16. IC50 value of K. gracilis leaf extract in 2A protease assay was 32.46 μg/ml for EV71. The result implied K. gracilis leaf extract inhibited the proteolytic activity of EV71 and CVA16 2A proteases. K. gracilis leaf extract also revises the NF-κB-mediated signaling that induced by the virus infected. K. gracilis leaf extract effective against enterovirus is via inhibited viral replication and viral 2A protease activity. In the other hand, K. gracilis stem extract, EA fraction, BuOH fraction and relative compounds processed low cyotoxicity. IC50 values of K. gracilis stem extract were 75.18 μg/mL for EV71, and 81.41 μg/mL for CVA16, respectively. Anti-EV activity of stem extract was weaker than leaf extract, but stem extract potently inhibited EVs replication. EA and BuOH fractions of stem extract also showed the competence on inhibiting viral 2A protease enzymatic activity. Among the ingredients, eupafolin reduced virus-induced expression of IL-6 and RANTES. In vivo experiments proved leaf and stem extract potently inhibiting viral titers in intestines of infected mice. Together with data of two parts showed K. gracilis extracts as potent therapeutics against EV71 and CVA16. K. gracilis, an indigenous herbal plant in Taiwan, could easily cultivate and develop antiviral drugs for treatment and prevention against EV71 and CVA16 infections. Yuan-Shiun Chang 張永勳 2014 學位論文 ; thesis 134 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 中國醫藥大學 === 中國藥學暨中藥資源學系博士班 === 102 === Kalanchoe gracilis (Crassulaceae) is a traditional Chinese medicinal, a.k.a. Da-Huan-Hun, and usually used in injuries, pain, fever and inflammation in Taiwan. In 1998, enterovirus 71 (EV71) and coxsackie A16 (CVA16) outbroke with severe or even fatal cases occurred in Taiwan, causing public health concern. EV71 and CVA16 become two major endemic agents of HFMD in children in Taiwan. There are not yet specific vaccines or antiviral drugs for treating enterovirus infection in clinic. In this study, extracts and compounds of K. gracilis leaf and stem were divided into two groups for investigating the antiviral activities against EVs. HPLC analysis indicated leaf and stem extracts exhibiting different ingredients, such as ferulic acid, quercetin and kaempferol in the leaf extract, as well as caffeic acid and eupafol in stem extracts. Plaque reduction assay indicated IC50 values of K. gracilis leaf extract were 35.88 μg/ml for EV71, and 42.91 μg/ml for CVA16, repectively. Leaf extract showed potent activity in the procedures of pre- and post-treatment for virus. Leaf extract inhibit the virus yield production to 90%. IC50 values of K. gracilis leaf extract in cell-based FRET assay were 40.82 μg/ml for EV71 and 47.84 μg/ml for CVA16. IC50 value of K. gracilis leaf extract in 2A protease assay was 32.46 μg/ml for EV71. The result implied K. gracilis leaf extract inhibited the proteolytic activity of EV71 and CVA16 2A proteases. K. gracilis leaf extract also revises the NF-κB-mediated signaling that induced by the virus infected. K. gracilis leaf extract effective against enterovirus is via inhibited viral replication and viral 2A protease activity. In the other hand, K. gracilis stem extract, EA fraction, BuOH fraction and relative compounds processed low cyotoxicity. IC50 values of K. gracilis stem extract were 75.18 μg/mL for EV71, and 81.41 μg/mL for CVA16, respectively. Anti-EV activity of stem extract was weaker than leaf extract, but stem extract potently inhibited EVs replication. EA and BuOH fractions of stem extract also showed the competence on inhibiting viral 2A protease enzymatic activity. Among the ingredients, eupafolin reduced virus-induced expression of IL-6 and RANTES. In vivo experiments proved leaf and stem extract potently inhibiting viral titers in intestines of infected mice. Together with data of two parts showed K. gracilis extracts as potent therapeutics against EV71 and CVA16. K. gracilis, an indigenous herbal plant in Taiwan, could easily cultivate and develop antiviral drugs for treatment and prevention against EV71 and CVA16 infections.
author2 Yuan-Shiun Chang
author_facet Yuan-Shiun Chang
Ching-Ying Wang
王靜瑩
author Ching-Ying Wang
王靜瑩
spellingShingle Ching-Ying Wang
王靜瑩
Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16
author_sort Ching-Ying Wang
title Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16
title_short Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16
title_full Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16
title_fullStr Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16
title_full_unstemmed Antiviral Ability of Kalanchoe gracilis against Enterovirus 71 and Coxsackievirus A16
title_sort antiviral ability of kalanchoe gracilis against enterovirus 71 and coxsackievirus a16
publishDate 2014
url http://ndltd.ncl.edu.tw/handle/5eqw58
work_keys_str_mv AT chingyingwang antiviralabilityofkalanchoegracilisagainstenterovirus71andcoxsackievirusa16
AT wángjìngyíng antiviralabilityofkalanchoegracilisagainstenterovirus71andcoxsackievirusa16
AT chingyingwang jiāláncàiyìzhìchángbìngdú71xíngjíkèshāqíbìngdúa16xíngzhīhuóxìngyánjiū
AT wángjìngyíng jiāláncàiyìzhìchángbìngdú71xíngjíkèshāqíbìngdúa16xíngzhīhuóxìngyánjiū
_version_ 1719210779927904256